Ocular Inflammation & Immunology

The Ocular Inflammation & Immunology department provides specialised care for patients with complex and sight-threatening inflammatory eye diseases. As a national referral centre, led by Dr Anita Chan (Head and Senior Consultant).

It manages a high clinical load of uveitis, scleritis, and systemic autoimmune-associated ocular conditions. Care is guided by protocol-based management and close collaboration with Rheumatology, Infectious Disease, and Oncology divisions. It has introduced safer intravitreal methotrexate protocols for intraocular lymphoma, supported by rapid-access clinics, early steroid-sparing treatments, and close monitoring. Moving forward, it continues to expand services and train new specialists to meet the evolving needs of patients. 

Our Care Services 

SNEC deals with a wide range of ocular inflammatory conditions - some of which result in significant ocular morbidity and are estimated to account for 5% - 15% of blindness. Common ocular inflammations seen at our department include:

• HLA-B27 related anterior uveitis
• Fuch's heterochromic iridocyclitis
• Posner schlossman syndrome
• Intermediate uveitis
• Behcet's disease
• Vogt-Koyanagi-Harada syndrome
• Ocular infections such as acute and chronic endophthalmitis
• Toxoplasmosis chorioretinitis
• Tuberculosis uveitis
• Ocular malignancies such as ocular lymphoma 

Our department also provides advanced diagnostic and therapeutic options.

Why Choose SNEC?

Quality Assurance

• The clinical service propagates a multidisciplinary care model, with patient complexity and volume comparable to leading global centres. It also collaborates with SERI on translational research.

Advanced Technology

• Offers therapeutic innovation, including in-house ophthalmic drug compounding, and early adoption of biologics and personalised immunosuppression strategies are tailored to Asian disease patterns, and specialised management of ocular lymphoma.

Training the Experts

• Engages and influences the medical community globally with active participation in international uveitis societies, consensus working groups, and global disease registries. 

4
ophthalmologists

> 6,700
outpatient visits a year

> 10

advanced diagnostic and therapeutic tests offered

"We often see patients with vision at risk from inflammation or lymphoma. Our goal is to intervene early, personalise treatment and walk with them through what can be a long and difficult journey. We’re constantly adapting, learning, contributing, and raising standards across the region."

Dr Anita Chan

Head and Senior Consultant

Ocular Inflammation & Immunology Department